ANIX Anixa Biosciences, Inc.
$2.76▲ +0.36%
Healthcare
Other
After hours
$2.90▲ +5.07%
Sep 11, 7:57 PM ET
Volume 388.7K
Avg Volume (10D) 367.7K
Key Metrics & Fundamentals
Market Cap
$95.95M
P/E Ratio
–
Div Yield
–%
52W Range
2.32 - 5.46
% vs 50 MA
-17.73%
% vs 200 MA
-12.50%
RSI-14
29.0
MACD Histogram
-0.0900
Beta (1Y vs SPY)
1.64
Free Cash Flow
-$1.77M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.73M
COGS
–
Operating Exp
$2.74M
Operating Income
-$2.74M
EBIT
-$2.74M
Pretax Income
-$2.63M
Net Income
-$2.61M
EPS (Diluted)
-0.08
Price & Volume History
Loading chart…
Recent News
Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
ACCESS Newswire · Sep 11, 2026 1:00 PM
Anixa Biosciences Interview Highlighting Breast Cancer Vaccine to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV
PR Newswire · Sep 9, 2026 12:35 PM
Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
PR Newswire · Sep 3, 2026 12:00 PM
Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy
PR Newswire · Aug 24, 2026 12:55 PM
Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire · Aug 18, 2026 12:45 PM
Anixa Biosciences (ANIX) Upgraded to Strong Buy: Here's What You Should Know
Zacks · Jul 22, 2026 4:00 PM
Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year?
Zacks · Jul 22, 2026 1:40 PM
New Strong Buy Stocks for July 22nd
Zacks · Jul 22, 2026 11:15 AM
Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date
PR Newswire · Jul 6, 2026 12:30 PM
Anixa Biosciences secures Korean patent for breast cancer vaccine
Pharmaceutical Technology · Jun 30, 2026 10:31 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ANIX's money flow as a full page
Social Sentiment
Avg -0.30 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.